Wasatch Advisors Inc Macrogenics Inc Call Options Transaction History
Wasatch Advisors Inc
- $19.9 Billion
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding MGNX
# of Institutions
130Shares Held
56MCall Options Held
28.3KPut Options Held
197K-
Bellevue Group Ag Kuesnacht, V89.93MShares$25.4 Million0.64% of portfolio
-
Armistice Capital, LLC New York, NY6.28MShares$16.1 Million0.29% of portfolio
-
Black Rock Inc. New York, NY5.4MShares$13.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.32MShares$11.1 Million0.0% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA3.18MShares$8.13 Million0.62% of portfolio
About MACROGENICS INC
- Ticker MGNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 61,458,800
- Market Cap $157M
- Description
- MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...